Aspiriant LLC’s Tableau Software, Inc. DATA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,118
Closed -$1.02M 237
2019
Q2
$1.02M Sell
6,118
-1,123
-16% -$148K 0.08% 107
2019
Q1
$922K Buy
7,241
+787
+12% +$99.4K 0.08% 118
2018
Q4
$775K Hold
6,454
0.06% 121
2018
Q3
$721K Sell
6,454
-2,262
-26% -$244K 0.06% 126
2018
Q2
$852K Sell
8,716
-2,823
-24% -$259K 0.07% 117
2018
Q1
$933K Buy
11,539
+6,214
+117% +$492K 0.08% 109
2017
Q4
$368K Sell
5,325
-2,263
-30% -$166K 0.11% 58
2017
Q3
$568K Sell
7,588
-5,325
-41% -$370K 0.05% 133
2017
Q2
$791K Sell
12,913
-100,334
-89% -$5.88M 0.07% 125
2017
Q1
$5.61M Buy
+113,247
New +$5.6M 0.48% 36

Other funds holding DATA

Aspiriant LLC's DATA Position: Q3 2019 in Review

Aspiriant LLC sold out of Tableau Software, Inc. (DATA) in Q3 2019, closing a stake of 6,118 shares — an estimated $1.02M sold.

Aspiriant LLC first reported a position in DATA in Q1 2017 and held it in 10 quarters. The position peaked at $5.61M in Q1 2017. 2 funds tracked by Wall St. Rank hold DATA as of Q3 2019.

  • Aspiriant LLC reported no remaining Tableau Software, Inc. position as of Q3 2019 after selling out during the quarter.
  • Aspiriant LLC sold 6,118 Tableau Software, Inc. shares in Q3 2019, an estimated $1.02M.
  • Aspiriant LLC first reported a position in Tableau Software, Inc. in Q1 2017 and held it in 10 quarters.
  • Aspiriant LLC's Tableau Software, Inc. position peaked at $5.61M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Tableau Software, Inc. as of Q3 2019.

Based on Aspiriant LLC's 13F filing for Q3 2019, filed 4 Nov 2019.